Loree, J. M., Tie, J., Samalin, E., Gill, S., Johnson, B., Grossman, J. E., O'Day, S., Chen, E. X., Karapetis, C. S., Fouchardière, C. D. L., Cheung, W. Y., Chan, K. K., Rutledge, C., Tu, D., O'Callaghan, C. J. (2026). The CO.33/BATTMAN trial: A phase 3 randomized study of botensilimab + balstilimab versus best supportive care in chemorefractory unresectable colorectal adenocarcinoma that is not dMMR/MSI-H.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3676